Copyright
©The Author(s) 2017.
World J Hepatol. Aug 18, 2017; 9(23): 1001-1007
Published online Aug 18, 2017. doi: 10.4254/wjh.v9.i23.1001
Published online Aug 18, 2017. doi: 10.4254/wjh.v9.i23.1001
Variable(s) | Group I | Group II | Group III | P value |
HCC group (n = 57) | Cirrhotic group (n = 57) | Control group (n = 57) | ||
Gender | ||||
Male | 37 (64.91) | 39 (68.42) | 40 (70.18) | 0.8289 |
Female | 20 (35.09) | 18 (31.58) | 17 (29.82) | |
Age (mean ± SD) (yr) | 55.9 ± 5.194 | 54.88 ± 9.907 | 54.3 ± 6.34 | 0.5087 |
Child Pugh classification | ||||
A | 10 (17.54) | 15 (26.32) | - | 0.527 |
B | 18 (31.58) | 16 (28.07) | - | |
C | 29 (50.88) | 26 (45.61) | - |
- Citation: Mohamed AA, Ali-Eldin ZA, Elbedewy TA, El-Serafy M, Ali-Eldin FA, AbdelAziz H. MicroRNAs and clinical implications in hepatocellular carcinoma. World J Hepatol 2017; 9(23): 1001-1007
- URL: https://www.wjgnet.com/1948-5182/full/v9/i23/1001.htm
- DOI: https://dx.doi.org/10.4254/wjh.v9.i23.1001